ANTONIO LIRAS MARTÍN-rekin lankidetzan egindako argitalpenak (10)

2023

  1. Expresión de factor V de la coagulación en distintas etapas del desarrollo embrionario en ratón

    LXIV Congreso Nacional de la SEHH. XXXVIII Congreso Nacional SETH. 38th World Congress of the International Society of Hematology (ISTH)

  2. La magia de las proteasas: De un factor v procoagulante y anticoagulante a un tratamiento equitativo de su deficiencia hereditaria

    Investigaciones DACIU 2022-2023: Una publicación que refleja los trabajos realizados por los participantes en el programa DACIU en su primera edición (Fundación Avanza), pp. 73-80

  3. The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  4. Treatment of congenital coagulopathies, from biologic to biotechnological drugs: The relevance of gene editing (CRISPR/Cas)

    Thrombosis Research, Vol. 231, pp. 99-111

2022

  1. Development and Characterization of a Factor V‐Deficient CRISPR Cell Model for the Correction of Mutations

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  2. Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models

    Frontiers in Veterinary Science, Vol. 9

  3. The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Gene and Cell Therapy in Dental Tissue Regeneration

    Human Tooth and Developmental Dental Defects - Compositional and Genetic Implications

  2. Gene therapy in hemophilia: Recent advances

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

  3. High mutational heterogeneity, and new mutations in the human coagulation factor v gene. Future perspectives for factor v deficiency using recombinant and advanced therapies

    International Journal of Molecular Sciences, Vol. 22, Núm. 18